Université Pierre Et Marie Curie (Paris 6)

Mor Research Applications Ltd.

Université Pierre Et Marie Curie

Zvi Laron

Claude Carelli

Gila Maor

The invention relates to peptides useful for inhibiting IGF-1 activity and their use as agents for inhibition of in vitro cell proliferation and for treatment of various diseases.

Methods for treating diseases with peptides that inhibit IGF-1

The invention provides a method and a composition for the treatment of infants age less than 2.5 years old defined as small for gestational age (SGA), including the use of hGH or any compound that increases blood levels of hGH or of IGF-I. Early use of the composition prevents the irreversible neurological and psychological damage of the children.

Method of treatment of small for gestational age infants under two years of age

The invention relates to peptides useful for inhibiting IGF-1 activity and their use as agents for inhibition of in vitrocell proliferation and for treatment of various diseases.

Method for inhibiting growth of chondrocytes in a subject by inhibiting IGF-1

The invention relates to peptides for modulate IGF-1 activity, a pharmaceutical composition comprising them as well as their applications as medicinal products and cell proliferation modulating agents in vitro.

Growing community of inventors

Ramat Efal, Israel

Zvi Laron